Trial intelligence / Profile preview

Phase IIb trial of TMC435 plus peginterferon alfa-2a and ribavirin in treatment-naive genotype 1 hepatitis C

2008-007147-13Phase 2Completed

Sponsor

Tibotec

Start

Mar 2009

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1